Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Citrate or heparin? study tests better lock for dialysis catheters in ICU

NCT ID NCT01962116

Disease control Sponsor: Centre Hospitalier Universitaire Dijon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether citrate or heparin is better for keeping dialysis catheters working longer in ICU patients with sudden kidney failure. 405 adults were randomly assigned to receive either citrate or heparin as a catheter lock solution. The goal was to see which solution helped the catheter stay in place without problems for more days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

405 people

The number who actually took part.

Started

Jun 2013

Finished

Dec 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged \> 18 years * Requiring RRT for acute renal insufficiency * For which a 1st non-tunneled catheter is placed * In the jugular or femoral position * After written informed consent has been obtained from the patient, a member of the family or a person of trust Exclusion Criteria: * Patient presenting active poorly controlled bleeding * Known allergy to citrate * Acute liver failure (Prothrombin level \<30%) * Thrombopenia \< 30 000/mm3 * Known or suspected heparin-induced thrombopenia * Known systemic bacterial infection at the time the catheter is placed * catheter in the subclavicular position * Persons not affiliated to a national health insurance scheme * Pregnant women * Adults under guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patients with acute renal insufficiency are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute kidney injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Patients with acute renal insufficiency

Contacts and locations

Locations

  • CHU Dijon

    Dijon, 21000, France